Illumina Diagnostic Test COVIDSeq to Detect SARS-CoV-2
Illumina (ILMN) was issued an Emergency Use Authorization (EUA) from the FDA for the first COVID-19 diagnostic test utilizing next-generation sequence technology. The authorization was granted for the Illumina COVIDSeq Test for the qualitative detection of SARS-CoV-2 RNA from respiratory specimens collected from individuals suspected . . .
This content is for paid subscribers.
Impacting News June 15, 2020